Her2-positive breast cancer - Globe Thesis

Keyword [Her2-positive breast cancer] Result: 21 - 40 \| Page: 2 of 3
21.	The Effect And Mechanism Of Aqueous Extract Of Myrrh On Proliferation,Migration,Invasion Of HER2-Positive Breast Cancer Cells SK-BR-3
22.	Expression Of MTDH,topo? In Pre-operative Neoadjuvant Chemotherapy Combined With Herceptin In Patients With HER2-positive Breast Cancer And Investigate The Prognosis
23.	The Molecular Mechanism And Clinical Significance Of MICA/B Expression In HER2-positive Breast Cancer
24.	Target Agents On First Line Therapy Of Advanced HER2-positive Breast Cancer:A Network Meta-analysis
25.	Preoperative Dose-dense Chemotherapy Or Postoperative Chemotherapy For Operative Triple Negative Or HER2-positive Breast Cancer:A Randomized Study
26.	Study On The Mechanism Underlying Valproic Acid Reversed Trastuzumab Resistance In HER2-positive Breast Cancer Cells
27.	The Analysis Of Diagnosis And Treatment In HER2 Positive Breast Cancer
28.	Therapeutic Evaluation Of HER2-positive Breast Cancer With Neoadjuvant Chemotherapy Combined With Targeted Therapy
29.	The Expression And Heterogeneity Analysis Of PD-1/PD-L1 In Triple-negative Breast Cancer And The Clinical Significance Of TIL
30.	Efficacy And Prognosis Of Trastuzumab With Or After Neoadjuvant Chemotherapy For HER2-positive Breast Cancer
31.	The Detection And Clinical Significance Of Total CtDNA And HER2 Copy Number During Neoadjuvant Chemotherapy Treatment With Trastuzumab In HER2 Positive Breast Cancer
32.	The Application Of Meta-analysis In The Study Of Tumor Biotherapy
33.	Efficacy And Safety Of Double Target Combined Chemotherapy For HER2 Positive Breast Cancer:A Systematic Review And Meta-analysis
34.	Human/rat HER2-specific Exosome-targeted T Cell Vaccine For HER2~+ Breast Cancer Immunotherapy
35.	Clinical Analysis Of Lapatinib In Combination With Capecitabine Versus Continued Use Of Trastuzumab In Advanced HER2-positive Breast Cancer Patients With Trastuzumab-resistance
36.	PAI-1 Induces Src Inhibitor Resistance Via CCL5 In HER2-positive Breast Cancer Cells
37.	The Relationship Between CRP And D-dimer With The Prognosis Of Advanced HER2 Positive Breast Cancer With Targeted Therapy
38.	Analysis Of Prognostic Factors And Establishment Of Prognostic Model Of Patients With HER2-positive Advanced Breast Cancer
39.	Heterogeneity Of HER2 Positive Breast Cancer
40.	The Suppressive Role Of Inhibitor Of Growth 4(ING4) In HER2-positive Breast Cancer Growth And Metastasis Through PTEN And Its Underlying Mechanism
<<First <Prev Next> Last>> Jump to